MEHMET OKCU to Dactinomycin
This is a "connection" page, showing publications MEHMET OKCU has written about Dactinomycin.
Connection Strength
0.172
-
Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implications. Pediatr Blood Cancer. 2015 Nov; 62(11):1925-8.
Score: 0.124
-
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2022 Jan 15; 128(2):317-325.
Score: 0.048